Annual report pursuant to Section 13 and 15(d)

8. Investment in Ruthigen (Details)

v2.4.0.8
8. Investment in Ruthigen (Details) (USD $)
12 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Equity Method Investments and Joint Ventures [Abstract]    
Aggregate fair value of consideration received by the Company $ 0  
Fair value of retained non-controlling interest by the Company 10,150,000  
Carrying amount on non-controlling interest in subsidiary 0  
Less: Carrying amount of the Ruthigen assets and liabilities (983,000)  
Gain (loss) on deconsolidation of Ruthigen $ 11,133,000 $ 0